Evidence map›Paper›PMID 37109886›Full record

ArticleMaterials (Basel, Switzerland)2023

Addressing Current Challenges in OSL Dosimetry Using MgB

Lily Bossin, Igor Plokhikh, Jeppe Brage Christensen, Dariusz Jakub Gawryluk, Yuuki Kitagawa, Paul Leblans, Setsuhisa Tanabe, Dirk Vandenbroucke, Eduardo Gardenali Yukihara

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. High-Resolution MgBMaterials (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lily BossinDepartment of Radiation Safety and Security, Paul Scherrer Institute, Forschungsstrasse 111, 5232 Villigen, Switzerland.ORCID 0000-0002-7355-1220
Igor PlokhikhDepartment of Radiation Safety and Security, Paul Scherrer Institute, Forschungsstrasse 111, 5232 Villigen, Switzerland.ORCID 0000-0003-1638-2771
Jeppe Brage ChristensenDepartment of Radiation Safety and Security, Paul Scherrer Institute, Forschungsstrasse 111, 5232 Villigen, Switzerland.ORCID 0000-0002-6894-381X
Dariusz Jakub GawrylukLaboratory for Multiscale Materials Experiments, Paul Scherrer Institute, Forschungsstrasse 111, 5232 Villigen, Switzerland.ORCID 0000-0003-4460-7106
Yuuki KitagawaNational Institute of Advanced Industrial Science and Technology (AIST), Ikeda, Osaka 563-8577, Japan.ORCID 0000-0001-5848-5299
Paul LeblansRadiology Division, Agfa NV, 2640 Mortsel, Belgium.ORCID 0000-0003-4576-1623
Setsuhisa TanabeGraduate School of Human and Environmental Studies, Kyoto University, Kyoto 606-8501, Japan.ORCID 0000-0002-7620-0119
Dirk VandenbrouckeRadiology Division, Agfa NV, 2640 Mortsel, Belgium.
Eduardo Gardenali YukiharaDepartment of Radiation Safety and Security, Paul Scherrer Institute, Forschungsstrasse 111, 5232 Villigen, Switzerland.ORCID 0000-0002-4615-6698

Funding

Swiss National Science Foundation 206021 177028
6 · The paper itself

Abstract

The objective of this work is to review and assess the potential of MgB4O7:Ce,Li to fill in the gaps where the need for a new material for optically stimulated luminescence (OSL) dosimetry has been identified. We offer a critical assessment of the operational properties of MgB4O7:Ce,Li for OSL dosimetry, as reviewed in the literature and complemented by measurements of thermoluminescence spectroscopy, sensitivity, thermal stability, lifetime of the luminescence emission, dose response at high doses (>1000 Gy), fading and bleachability. Overall, compared with Al2O3:C, for example, MgB4O7:Ce,Li shows a comparable OSL signal intensity following exposure to ionizing radiation, a higher saturation limit (ca 7000 Gy) and a shorter luminescence lifetime (31.5 ns). MgB4O7:Ce,Li is, however, not yet an optimum material for OSL dosimetry, as it exhibits anomalous fading and shallow traps. Further optimization is therefore needed, and possible avenues of investigation encompass gaining a better understanding of the roles of the synthesis route and dopants and of the nature of defects.

Indexed as

luminescence dosimetryMgB4O7OSLphosphors

Identifiers

PMID37109886
PMCPMC10142933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.